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Abstract
Background: The metabolic pathway of folate is thought to influence DNA stability either by inducing single/double
stranded breaks or by producing low levels of S-adenosyl-methionine leading to abnormal gene expression and
chromosome segregation. Polymorphisms in the genes encoding enzymes in the folate metabolism pathway show distinct
geographic and/or ethnic variations and in some cases have been linked to disease. Notably, the gene Methylenetetrahy-
drofolate reductase (MTHFR) in which the homozygous (TT) state of the polymorphism c.665C.T (p.A222V) is associated
with reduced specific activity and increased thermolability of the enzyme causing mild hyperhomocysteinemia. Recently
several studies have suggested that men carrying this polymorphism may be at increased risk to develop infertility.
Methodology/Principal Findings: We have tested this hypothesis in a case/control study of ethnic French individuals. We
examined the incidence of polymorphisms in the genes MTHFR (R68Q, A222V and E429A), Methionine synthase reductase
MTRR; (I22M and S175L) and Cystathionine beta-synthase (CBS; G307S). The case population consisted of DNA samples from
men with unexplained azoospermia (n=70) or oligozoospermia (n=182) and the control population consisted of
normospermic and fertile men (n=114). We found no evidence of an association between the incidence of any of these
variants and reduced sperm counts. In addition haplotype analysis did not reveal differences between the case and control
populations.
Conclusions/Significance: We could find no evidence for an association between reduced sperm counts and
polymorphisms in enzymes involved in folate metabolism in the French population.
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Introduction
The metabolism of folate is key for the maintenance of genome
integrity due to its role in DNA synthesis, repair and methylation
[1,2]. Methylenetetrahydrofolate reductase (MTHFR) catalyzes the
reduction of 5, 10-methylenetetrahydrofolate to 5-methyltetrahy-
drofolate (MTHF), the predominant circulatory form of folate and
carbon donor for the re-methylation of homocysteine to methio-
nine. Thus, MTHFR is thought to participate in the provision of
nucleotides essential for DNA synthesis and repair. Methionine, in
its activated form, S-adenosyl methionine (SAM), is the methyl
donor of many biologic transmethylation reactions [1,2]. A
decreased pool of methionine may therefore also affect DNA
methylation and this is supported by the observation that some
MTHFR variants are associated with DNA hypomethylation [3].
Several polymorphisms have been described that result in
amino acid changes, which could lead to altered MTHFR
enzymatic activity [1,4]. A base change from C to T at nucleotide
position 665 (also known as C677T) of the MTHFR gene results in
the substitution of valine for alanine (p.A222V). Both heterozygous
Ala/Val and homozygous Val/Val variants have reduced
MTHFR enzyme activity compared with the homozygous Ala/
Ala form, due to increased thermolability of the protein [5]. When
compared to 665CC individuals, carriers of 665TT have ,34%
residual MTHFR activity and 665CT individuals have ,71%
residual MTHFR activity measured in vitro [6]. Individuals
(particularly with a low folate status) carrying these variants can
present with mild hyperhomocysteinemia [5].
A second polymorphism in MTHFR (c.A1286A.C; p.E429A)
also results in reduced enzymatic activity in vitro, but by itself, it is
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6540not associated with higher plasma homocysteine (Hcy) or a lower
plasma folate concentration [7]. However, combined heterozy-
gosity with the c.655C.T polymorphism is associated with
reduced MTHFR-specific activity, higher Hcy, and decreased
plasma folate levels [7]. Both the c.1286A.C and c.665C.T
polymorphism are associated with DNA hypomethylation [3]. A
third MTHFR polymorphism leading to an arginine to glutamine
change (c.203G.A; p.R68Q) has been described but the affect of
this change on enzymatic activity is unknown.
Methyltetrahydrofolate homocysteine methyltransferase (MTR)
converts 5-methyltetrahydrofolate and homocysteine to tetrahy-
drofolate and methionine. Methionine synthase reductase
(MTRR) plays a crucial role in maintaining the active state of
MTR through the reductive methylation of cob(II)alamin.
Disturbances in the catalytic activity of MTRR could lead to
higher levels of Hcy, and this can be a risk factor for neural tube
defects (NTD), [8,9]. The most common polymorphism reported
in the MTRR gene is an isoleucine to methionine change at
position 22 (c.66A.G, p.I22M). Although the p.I22M polymor-
phism does not appear to alter the catalytic activity of the protein,
the 66GG genotype is associated with a modest but significant
decrease in plasma tHcy levels [10]. Other association studies have
suggested that the p.I22M polymorphism is modest risk factor for
Down syndrome [11] and NTD [9]. A second common MTRR
polymorphism, c.524C.T (p.S175L), has been investigated in
only a single study, which failed to detect an association between
this polymorphism and NTDs [12].
A third key enzyme in folate metabolism is cystathionine b-synthase
(CBS), which catalyses irreversible cystathionine synthesis from
homocysteine and serine. Disturbances in this process can lead to
an increased cellular Hcylevel and the most common type of inherited
homocystinuria in the human is caused by a deficiency in CBS.
Cystathionine is a substrate for cysteine synthesis, which is catalysed by
cystathioninase. The gene encoding cystathionine synthase (CBS) has
been localized on chromosome 21 (21q22.3) in a region correlated
with Down syndrome phenotype. A frequent mutation in the CBS
gene in Caucasian patients, c.919G.A (p.G307S), is one of the most
common causes of homocystinuria in patients of Celtic origin [13] and
this mutation accounted for 71% of alleles in Irish homocystinuria
patients [14]. This mutation has been described in individuals of
French, Scottish, English and Irish Ancestry [13–15] and is probably
specific for North-west European populations.
Recently several association studies have suggested that
polymorphic variants in the MTHFR gene may be associated
with reduced sperm counts in the human leading to male infertility
in some populations [16–23]. Here, we describe an association
study between 3 variants in MTHFR, two variants in MTRR and
the p.G307S mutation in the CBS gene and reduced sperm counts
in otherwise healthy individuals of French ethnic origin that sough
treatment for infertility. We failed to detect an association between
any of these variants and unexplained reduced sperm counts
leading to male infertility. These data suggest that in our study
population, genetic variants in enzymes involved in folate
metabolism do not have a significant impact on sperm counts.
Materials and Methods
Patient Recruitment
Patients presenting with idiopathic infertility or normospermic
fertile donors were recruited from Tenon Hospital, Paris and
Saint-Etienne Hospital, Saint-Etienne. All patients and controls
were of French ethnic origin as determined by self-report of
patients. Exclusion criteria included known genetic causes of
infertility such as chromosome anomalies, Y chromosome AZF
deletions [24] and presumed genetic risk factors for male infertility
[Y chromosome gr/gr deletions; 25]. The final clinical breakdown
of the study population was azoospermic (n=70), oligozoospermic
(,20610
6sperm/ml; n=182), normospermic and fertile
(.20610
6/sperm/ml and father of at least one child; n=114).
Semen analysis was performed on at least two separate occasions.
Ethics Statement
All patients provided informed consent prior to participation in
this study. The study was approved by the Comite Consultatif de
Table 1. SNPs investigated in this study together with the PCR primers and detection method.
Gene Chrom. SNP NCBI A.Nu
AA
substitution
Base
change
Detection
method PCR primers AT
FS
(bp) DFS (bp)
MTHFR 1 c.203G.A rs2066472 p.R68Q A/G PCR+TaqI dig 59CGA TTG GAA TCT GGT GAC AA39
59A C CT T GC A TG A GT T TA C CT T G 3 9
56uC 101 48+53
c.665C.T rs1801133 p.A222V C/T PCR+HinfI dig 59CCA AAG GCC ACC CCG AAG39
59GAA AGA TCC CGG GGA CGA TG39
56uC 180 75+105
c.1286A.C rs1801131 p.E429A A/C PCR+MboII dig 59CTT TGG GGA GCT GAA GGA CTA
CTA C39 59CAC TTT GTG ACC ATT
CCG GTT TG39
56uC 163 56+31+30
+28+18
MTRR 5 c.66A.G rs1801394 p.I22M A/G PCR+NdeI dig 59GCA AAG GCC ATC GCA GAA GAC39
59TGG TGG TAT TAG TGT CCT TTT39
56uC 179 22+157
c.524C.T rs1532268 p.S175L C/T PCR+TaqI dig 59CGT GGA TTG CTG GAC TCT G39
59AGC AGC TCT GAC TTC ACA AGG39
56uC 133 101+32
CBS 21 c.919G.A - p.G307S A/G PCR+PvuII dig 59ATC ATT GGG GTG GAT CCCGA 39
59ACC GTG GGG ATG AAG TCG CAG39
60uC 113 92+21
Chrom: Chromosome.
SNP: single nucleotide polymorphism.
NCBI AN: NCBI Accession Number.
AA: Amino Acid.
Dig: Digestion.
AT: Annealing Temperature.
FS: Fragment size.
DFS: Digestion Fragment size.
doi:10.1371/journal.pone.0006540.t001
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Dieu- Paris (CCPPRB Nu97324). All clinical investigations were
conducted according to the principles expressed in the Declaration
of Helsinki.
Molecular analysis
Single-nucleotide polymorphism analysis. A total of 6
single-nucleotide polymorphism (SNPs) in key genes in folates
metabolism where selected for this study. In this study, we used a
combination of direct sequencing of PCR products and PCR/
restriction fragment length polymorphism (RFLP) assays and
genotyped the SNPs in well-defined ethnic French case and
control populations. The methodology and the oligonucleotides
used in the study are outlined in table 1.
Genotyping. A PCR protocol was applied in genotyping all
SNPs. PCR was carried out in a volume of 25 ml containing 30 ng
genomic DNA, 1.5 mM MgCl2, 200 mM each deoxynucleotide
triphosphate, 2 mM each primer, 0.5 U Taq DNA polymerase
(Bioline, London, U.K.) and 106reaction buffer. PCR consisted
of an initial denaturation at 94uC for 10 min, followed by 35 cycles
of 94uC for 30 s, annealing temperature (table 1) for 30 s, and
72uC for 30 s, with a 7-min 72uC final extension. The PCR
amplicons were digested by those restriction endonucleases
corresponding to their respective SNPs (New England Biolabs,
Beverly, Mass.). Digestion products were electrophoresed on a 3%
agarose gel. In addition, the allelic status of 96 DNA samples was
confirmed by direct sequencing of PCR products to validate the
results obtained by RFLP-PCR.
Statistical analysis
In order to assess a possible distortion in allele frequencies
between cases and controls, for the different polymorphisms tested,
we performed a chi-square test with one degree of freedom for both
allelic and genotypic distributions between the groups of cases and
controls. Further, we tested if certain allelic combinations could be
associated withanincreased risk ofinfertilityinanyofthe genes.For
that, we reconstructed haplotypes from unphased genotypic data
using the accelerated Expectation Maximization algorithm imple-
mented in Haploview v3.1. Association testing for the haplotypes as
well as the measure of linkage disequilibrium (D’) between all pairs
of SNP’s was performed using the same software. p value was
determined using a x2 test for the distribution of haplotype alleles
between the cases and controls. Significant associations were
defined by a p-value below 0.05. Haplotypes occurring at less than
1% frequency were excluded from the analysis.
Results
We analysed 3 MTHFR common variants (c.203G.A, p.R68Q;
c.665C.T, p.A222V and c.1286A.C, p.E429A), 2 MTRR
polymorphisms (c.66A.G, p.I22M and c.524C.T, p.S175L) and
one CBS mutation (c.919G.A, p.G307S). We compared the
distributions of the MTHFR and MTRR genotypes between the
cases and controls (tables 2 and 3). The MTHFR genotypes
distribution for the c.665C.T (p.A222V) and c.1286A.C
(p.E429A) polymorphism were in Hardy-Weinberg equilibrium
(respectively p=0.20 and p=0.22), but not for the c.203G.A
(p.R68Q) polymorphism (p=0.002). For this polymorphism, geno-
types distribution was in Hardy-Weinberg equilibrium for cases with
azoospermia (p=1) but not for cases with oligozoospermia
(p=0.002). The MTRR genotypes distribution for the c.524C.T
(p.S175L) polymorphism was in Hardy-Weinberg equilibrium
(p=0.091) but not for the c.66A.G (p.I22M) polymorphism
(p=0.015). The lack of Hardy-Weinberg equilibrium for some of
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PLoS ONE | www.plosone.org 4 August 2009 | Volume 4 | Issue 8 | e6540these markers has been noted elsewhere and this could be a signature
of either, genetic drift, non-random mating patterns or an indication
of selection acting on specific genotypes. If the latter hypothesis is
correct we do nothave evidencethat this is due to an affect of reduced
sperm counts in the male. For all the polymorphisms we did not
observe any statistically significant association with reduced sperm
counts in the French population. There was no association between
the two phenotypes (azoospermia or oligozoospermia). The Bonfer-
roni correction was not applied since significance was not observed
with all markers between the case and control cohorts.
The MTHFR c.665C and c.1286C polymorphic sites are only
2.1 kb apart and are in strong linkage disequilibrium (see figure 1).
It has been suggested that these polymorphisms are the result of
independent founder effects in which each variant evolved on a
separate wild-type allele.
We did not identify any individual carrying the CBS c.919G.A
(p.G307S) mutation.
Haplotype analysis
Haplotypes for the MTHFR and MTRR genes were recon-
structed using the accelerated Expectation Maximization algo-
rithm implemented in Haploview v3.1. We identified three
haplotypes that characterize 93% of all haplotypic diversity in
the MTHFR gene. There was no statistical significant difference in
the distribution of these haplotypes between case and control
cohorts. The analysis of the MTRR gene revealed 4 major
haplotypes. There was no difference in the distribution of the
haplotypes between the case and control groups (tables 4 and 5).
Discussion
Changes in folate status could affect spermatogenesis in two
ways: 1) by causing DNA hypomethylation and thereby disrupting
gene expression and 2) inducing uracil misincorporation during
DNA synthesis leading to errors in DNA repair, strand breakage
and chromosomal anomalies. There is considerable experimental
evidence that key enzymes in the folate metabolism are necessary
for male spermatogenesis. Mice that lack the Mthfr gene exhibit
hyperhomocystenemia, significantly decreased S-adenosylmethio-
nine levels, global DNA hypomethylation and developmental
retardation with severe neuropathology [26]. These mice also
showed delayed maturation of the external genitalia but appeared
to be fertile [26]. However, extensive backcrossing of these mice to
a BALB/c background resulted in spermatogenic failure during
early postnatal development and resultant complete male infertility
[27]. Fertility could be restored in a subset of Mthfr
2/2 mice by
supplementing the diet with betaine, a choline directive that can
serve as an alternative methyl donor for the remethylation of
Figure 1. Haplotype organisation of the MTHFR gene in the CEPH pedigrees. The haplotype block pattern was constructed using the
Haploview program using data from the HapMap project. The number in each cell represents the LD parameter D’ (x100). Each cell is colour
graduated relative to the strength of LD between two markers. Red cells without numbers refer to pairs of SNPs in significant and maximum LD (i.e.
D’=1). Blue cells also represent pairs of SNPs with D’=1, although in these case the observed LD levels are not statistically significant. The entire gene
lies within a large haplotype block, within which two minor blocks can be identified. The rs numbers are the SNP ID in the NCBI SNP database. The
marker rs1801131 (E429A) is located in haplotype block 1, marker rs2066472 (not shown) is located within haplotype block 2 and the markers A222V
is located between these two haplotype blocks.
doi:10.1371/journal.pone.0006540.g001
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PLoS ONE | www.plosone.org 5 August 2009 | Volume 4 | Issue 8 | e6540homocysteine. In the human, an increase in sperm quality (such as
sperm count and motility) after one cycle of spermatogenesis of
treatment with folinic acid has been reported [28]. These data
indicate that folate metabolism plays a key role in the maintenance
of spermatogenesis.
Recently, a double-blind trial of folic acid and zinc sulfate
(zinc is an important cofactor of dihydrotestosterone reductase)
demonstrated a significant incre a s ei nt o t a ln o r m a ls p e r mc o u n t s
although the influence on fertility was not investigated [29]. A
follow-up study revealed that this effect occurred in men with a
wild type MTHFR 665C/C background and there was no
significant increase in sperm concentration observed in either
the MTHFR heterozygous 665C/T or MTHFR homozygous T/
T cohorts [21]. Although this suggests that the p.A222V
mutation may affect fertility, the authors observed that the
homozygous prevalence rate in subfertile and fertile men was not
significantly different. Therefore although this study suggests
that folate supplement may improve spermatogenesis, it did not
indicate that this known functional variant in MTHFR is a risk
factor for male infertility [21]. Meta-analysis has revealed a
significant association between the MTHFR c.665C.Tp o l y -
morphism and male fertility (OR 1.39, 1.15–2.69 95% CI,
p=0.0006; 30). A summary of the association studies is provided
in table 6.
How is it possible to reconcile the apparently conflicting data
between studies? One explanation could be population substruc-
ture [31]. There is considerable ethnic and geographic variation in
the distribution of the C665T polymorphism. The MTHFR
c.665C.T polymorphism is less frequent among Africans than
among Caucasians [32,33]. The frequency of the MTHFR
c.1286A.C (p.E429A) variant allele also differs across popula-
tions, especially among Caucasian and Chinese populations,
where the frequency of the C allele is nearly twice as low in
Chinese as in Caucasians [34]. In the absence of a suitable internal
genomic control it is possible that associations could be caused by
population stratification rather than a causal link with the
phenotype. Moreover gene-nutrient/environmental and gene-
racial/ethnic interactions have been shown to affect the impact
of these MTHFR genetic variants [4]. Apart from ascribing the
results of previous small studies to false-positive associations, it is
also possible that the positive and negative associations reflect that
the MTHFR c.665C.T polymorphism is not causal itself but
merely in linkage disequilibrium with the causal mutation. The
extent of linkage disequilibrium across the MTHFR locus is shown
in figure 1. Different founder effects could then explain the
contradicting associations. In either of these scenarios it is clear
that association studies with a larger sample size and hence power
of study need to be performed to identify a modest risk associated
with these polymorphisms. The power of a study is the probability
of successfully detecting an effect of a particular size and it is a
major challenge to achieve adequate power to detect subtle
associations for a complex trait, such as unexplained reduced
sperm counts, while minimizing the risk of false positives. In whole
genome scans, standard power calculations show that up to 1000
participants are required to detect major gene main effects and at
least 4,000 samples are required to detect small effects [35].
However, some studies have suggested that strong associations can
be detected even in modestly sized samples [36]. In a candidate
loci approach we identified a Y chromosome haplogroup
associated with reduced sperm counts (Odd Ratio 8.92 [2.8–
28.5] (95% confidence limits) in a cohort of 171 case and control
subjects [37]. It is interesting to note that the studies with larger
cohorts are those who report modest associations with MTHFR
polymorphisms.
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Table 5. Associations between reduced sperm counts and the most common MTRR haplotypes.
Haplotype Frequency Cases (alleles) Controls (alleles) Chi2 p
n% n %
GC 0.352 165 33.02 78 34.12 0.032 0.8580
GT 0.270 125 24.98 61 26.84 0.199 0.6556
AC 0.229 109 21.78 49 21.58 0.021 0.8860
AT 0.149 73 14.62 30 13.07 0.393 0.5310
doi:10.1371/journal.pone.0006540.t005
Table 4. Associations between reduced sperm counts and the most common MTHFR haplotypes.
Haplotype Frequency Cases (alleles) Controls (alleles) Chi2 p
n% n %
GCA 0.400 201 40.26 87 38.07 0.217 0.6410
GTA 0.290 144 28.78 65 28.33 0.0020 0.9627
GCC 0.261 127 25.48 60 26.4 0.114 0.7360
GTC 0.034 13 2.68 11 5 2.647 0.1037
doi:10.1371/journal.pone.0006540.t004
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